Delivery Order SPE2DB22D1202-SPE2DB24FVNC7

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide 27 mg Concerta ER tablets. The $6,833.60 firm fixed-price contract has a completion date of September 30, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a range of medical commodities to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 100 tablets of Concerta ER 27 mg, a pharmaceutical product. The contract has a firm fixed price of $5,192.34 and a completion date of July 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,741.40 firm-fixed-price delivery order is for the supply of 4565256472 Concerta ER 27 mg tablets. The contract has an ultimate completion date of July 26, 2024. AmerisourceBergen is delivering these pharmaceutical products under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Concerta ER 27 mg tablets. The contract has a ceiling value of $1,063.33 and a completion date of July 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999 through December 2025. This IDC enables the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Concerta ER 27 mg tablets. The contract has a ceiling value of $35,282.66 and a completion date of September 11, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Concerta ER 54 mg tablets. The $9,636.62 firm-fixed-price contract has an ultimate completion date of September 24, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $4,922.83 firm-fixed-price contract is for the delivery of 4,565,309,353 units of the pharmaceutical product Concerta ER 27 mg tablet. The contract has an ultimate completion date of August 1, 2024 and was awarded on July 31, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Concerta ER 27 mg tablets. The $11,389.72 firm fixed price award has an ultimate completion date of August 29, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a wide range of medical commodities to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $20,516.64 firm fixed-price contract is for the delivery of Concerta ER 27 mg tablets in quantities of 100s. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications to support various federal healthcare programs and facilities. This contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Concerta ER 18 mg tablets. The contract has a ceiling value of $15,494.74 and an ultimate completion date of July 30, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen is the prime contractor and will be responsible for providing the pharmaceutical product to support the...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVNC7
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets. The $3,604.70 firm fixed-price contract has an ultimate completion date of September 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/10/24, 2:38 PM